| Financial Year |
March 31 2023 |
| Monetary Funds |
662,272,514.87 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
119,513,105.04 |
| Advances to Suppliers |
37,888,417.89 |
| Other Receivables |
16,472,651.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
404,871,067.91 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
5,680,315.33 |
| Total Current Assets |
1,246,698,072.04 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
3,600,030.17 |
| Investment Properties |
-- |
| Fixed Assetes |
1,432,881,210.69 |
| Under-construction Projects |
328,361,365.32 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
711,508,875.40 |
| Oil and Gas Assets |
-- |
| Intangible Assets |
41,930,613.72 |
| R&D expenses |
-- |
| Goodwill |
1,996,446.14 |
| Long-Term Deferred and Prepaid Expenses |
3,531,480.85 |
| Deferred Income Tax Assets |
2,088,619.23 |
| Other Non-Current Assets |
20,539,432.50 |
| Sub-Total of Non-Current Assets |
2,672,836,826.37 |
| Total Assets |
3,919,534,898.41 |
| Short-Term Loans |
269,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
85,137,601.00 |
| Accounts Payable |
338,075,237.89 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
69,236,650.57 |
| Taxes Payable |
17,171,142.43 |
| Interest Payable |
-- |
| Dividend Payable |
24,078,528.83 |
| Other payables |
158,113,306.32 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
9,307,617.40 |
| Other Current Liabilities |
4,054,903.85 |
| Sub-Total of Current Liabilities |
984,715,673.41 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
580,218.10 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
339,071,631.43 |
| Total Liabilities |
1,323,787,304.84 |
| Paid-In Capital(Or Share Stock) |
320,190,246.00 |
| Capital Surplus |
1,372,236,372.83 |
| Surplus Reserve |
74,658,667.08 |
| LESS:Treasury Stock |
61,325,190.82 |
| Undistributed Profits |
658,161,332.07 |
| Minority Stockholder's Interest |
231,826,166.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,363,921,427.16 |
| Owner's Equity（Stockholder's Equity） |
2,595,747,593.57 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,919,534,898.41 |
